Host

Cristina João, Myeloma Lymphoma Research Group

Venue

Seminar room

Host

Christa Rhiner, Stem Cells and Regeneration Lab

Venue

Seminar room

The Champalimaud Foundation has always been at the intersection of cutting-edge science, and exceptional care. 

Specialising in cutting-edge cancer treatment, neuropsychiatry, and experimental clinical research, the Champalimaud Clinical Centre is committed to advancing personalised medicine through groundbreaking research, merging advanced technology with human-centred care.

Watch the video to see how the Champalimaud Foundation has been transforming healthcare and improving lives for the past 20 years—and how we’ll continue to do so in the future.

An international team, co-led by Adriana Sánchez-Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown for the first time the important role of Survivin – a protein that has key roles in regulating cell division and inhibiting apoptosis (programmed cell death) – in the initiation and formation of a basal cell carcinoma, the most common human skin cancer. Their results have now been published in the print edition of January 8, 2025, of the journal Cell Discovery.

The future of oncological surgery relies on the development of scientific research skills, and the Surgical Oncology Research Programme offers a unique opportunity for clinical and academic growth, with a personalised doctoral path, a flexible curriculum, and ample opportunities for professional development, mentorship, and networking.

From groundbreaking scientific research to compassionate, patient-centered clinical care, the Foundation is committed to developing innovative solutions for complex challenges, all with the goal of improving lives and inspiring hope.

Founded in the beginning of the 21st century, it carries forward the visionary legacy of António Champalimaud, advancing science and healthcare for the greater good of humanity.

Join us in discovering how, together, we are shaping a brighter future.

Date and time:

20 January 2025 – 12:00

Location:

Champalimaud Foundation Auditorium

Description:

Conventional Dendritic Cells – Ecology, Diversity, and Functio

Carlos Minutti (Immunoregulation Lab)

Moderator: Cristina João (Myeloma Lymphoma Research Group)

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab

Venue

Seminar room

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.

Breast Imaging, part of the Breast Unit at the Champalimaud Clinical Center in Lisbon, is looking for a Radiologist dedicated to breast diagnosis and intervention to join the Breast Imaging team, which consists of 4 radiologists fully dedicated to breast diagnosis and intervention.